Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn S Zur Bonsen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Biomedicines|November 27, 2025
Navigating the Therapeutic Landscape of Non-Infectious Uveitis Despite Major GapsUwe Pleyer, Lynn S Zur Bonsen
Pathologie (Heidelberg, Germany)|May 4, 2026
[Ophthalmic pathology grossing: The globe]Ebba J Nissen, Lynn S Zur Bonsen, Andreas Erbersdobler
Cells|January 11, 2022
Findings and Graduation of Sarcoidosis-Related Uveitis: A Single-Center StudyLynn S Zur Bonsen, Dominika Pohlmann, Anne Rübsam, et al.
Biomedicines|January 8, 2025
Adalimumab Autoantibodies in Uveitis Patients: Do We Need Routine Drug Monitoring?Lynn S Zur Bonsen, Vitus A Knecht, Anne Rübsam, et al.
Journal of Ophthalmic Inflammation and Infection|November 21, 2024
Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitisLynn S Zur Bonsen, Daniel Schulze, Steffen E Künzel, et al.
Infection|April 17, 2026
QuantiFERON-TB gold test: a valuable diagnostic tool for tubercular uveitis in non-endemic regionsSebastian Albus, Antonia Koch, Uwe Pleyer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 13, 2021
Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapyConstanze A Jakwerth, Adam M Chaker, Ferdinand Guerth, et al.
Allergy|April 30, 2026
TNF Pathway-Mediated Tolerogenic T-Cell Trajectory Driven by Allergen ImmunotherapyHelen S Charles, Amr A Gabr, Shu-Hung Wang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Biomedicines|November 27, 2025
Navigating the Therapeutic Landscape of Non-Infectious Uveitis Despite Major GapsUwe Pleyer, Lynn S Zur Bonsen
Pathologie (Heidelberg, Germany)|May 4, 2026
[Ophthalmic pathology grossing: The globe]Ebba J Nissen, Lynn S Zur Bonsen, Andreas Erbersdobler
Cells|January 11, 2022
Findings and Graduation of Sarcoidosis-Related Uveitis: A Single-Center StudyLynn S Zur Bonsen, Dominika Pohlmann, Anne Rübsam, et al.
Biomedicines|January 8, 2025
Adalimumab Autoantibodies in Uveitis Patients: Do We Need Routine Drug Monitoring?Lynn S Zur Bonsen, Vitus A Knecht, Anne Rübsam, et al.
Journal of Ophthalmic Inflammation and Infection|November 21, 2024
Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitisLynn S Zur Bonsen, Daniel Schulze, Steffen E Künzel, et al.
Infection|April 17, 2026
QuantiFERON-TB gold test: a valuable diagnostic tool for tubercular uveitis in non-endemic regionsSebastian Albus, Antonia Koch, Uwe Pleyer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 13, 2021
Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapyConstanze A Jakwerth, Adam M Chaker, Ferdinand Guerth, et al.
Allergy|April 30, 2026
TNF Pathway-Mediated Tolerogenic T-Cell Trajectory Driven by Allergen ImmunotherapyHelen S Charles, Amr A Gabr, Shu-Hung Wang, et al.
Pageof 1